We’re reviewing the distinctions between SuspendIt and SuspendIt Anhydrous, as well as how revisions to USP Chapter 795 will guide beyond use dates (BUDs) for aqueous and nonaqueous oral dosage forms.

PCCA Clinical Compounding Pharmacist Sebastian Denison, RPh, FAARM (candidate), updates a 2016 Apothagram article and shares heart healthy tips that reignite the libido.

PCCA Director of Formulations Melissa Merrell Rhoads, PharmD, offers insights on working with SuspendIt Anhydrous in oral suspension formulations

A modular compounding cleanroom is a great way to meet evolving regulatory requirements and standards. Learn the basics of a modular cleanroom in the first in a series of articles on Modular Compounding Cleanrooms.

Our PCCA Clinical Compounding Pharmacist Don Bottoni continues to discuss the gut-brain connection and ways to restore gut health.

Our PCCA Clinical Compounding Pharmacist Don Bottoni reviews the gut-brain connection and how it plays a major role in health and disease.

PCCA Senior Formulation Pharmacist Fabiana Banov offers flavoring tips that may make medicines tastier for children, pets and adults.

Clarification from the FDA and our industry partner, APC, reinstates sales and shipments of Thyroid USP (Porcine) (PCCA #30-1467) to compounding pharmacies.

PCCA Sr. Formulations Specialists summarize our many oral base vehicles to help guide you on choosing the most appropriate base for your compound.

Accelerate your compounding pharmacy’s performance with your existing staff. PCCA Members: Take advantage of a huge discount from December 5 to December 9 during our 10 Days of Deals!